Preclinical evaluations of a vaccine based on DC transfected with truncated LT mRNA showed an induction of antigen-specific CD8+ T cells from blood of healthy donors and even higher numbers with cells derived from MCC patients, and it holds potential for adoptive cellular immunotherapy [250]. This evidence concerns the gene CD8A and Merkel cell skin cancer.